Restless Legs Syndrome, also known as Willis-Ekbom disease , is a sleeping disorder that produces an urge to move one’s legs, often accompanied by abnormal leg sensations. The International Restless Legs Syndrome Study Group developed a series of five standards in 2012. Restless Legs Syndrome is common and is associated with multiple risk factors. These risk factors include female gender, chronic renal disease, pregnancy, iron deficiency, anxiety, insomnia, and depression. Treatment for this disorder ranges from behavioral therapy such as mental stimulation, walking or any type of physical exercise to pharmacological therapy, including ropinirole, pramipexole and rotigotine patches, gabapentanoid agents, and opioids, depending on the severity of the disease.
KeywordsRestless leg syndrome Iron deficiency Ropinirole Pramipexole
- 4.Picchietti DL, Hensley JG, Bainbridge JL, Lee KA, Manconi M, McGregor JA, Silver RM, Trenkwalder C, Walters AS, International Restless Legs Syndrome Study Group (IRLSSG). Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Med Rev. 2015;22:64–77.CrossRefGoogle Scholar
- 5.Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Med. 2014;15(8):860–73.CrossRefGoogle Scholar